Critical Pathways in Cardiology最新文献_第6页

Updating a Healthcare System-wide Clinical Pathway for Managing Chest Pain and Acute Coronary Syndromes. 更新医疗保健系统范围内管理胸痛和急性冠状动脉综合征的临床途径。

Critical Pathways in Cardiology Pub Date : 2023-12-01 Epub Date: 2023-09-28 DOI: 10.1097/HPC.0000000000000334

Robert S Zilinyi, Baruch S Fertel, Betty C Chang, Liliya Abrukin, Edward H Suh, Osman R Sayan, Matthew McCarty, Jennifer A Stant, Taylor Chuich, Emily T Smyth, Gerald Neuberg, Michael B Collins, Ajay J Kirtane, Jeffrey Moses, LeRoy Rabbani

引用次数: 0

Higher Heart Rate Is Independently Associated With Abnormal Body Mass Index in a J Shape Pattern. 较高的心率与J型异常体重指数独立相关。

Critical Pathways in Cardiology Pub Date : 2023-09-01 Epub Date: 2023-05-31 DOI: 10.1097/HPC.0000000000000326

Lucy Hickcox, Sharon Bates, Mehrnoosh Hashemzadeh, Mohammad Reza Movahed

{"title":"Higher Heart Rate Is Independently Associated With Abnormal Body Mass Index in a J Shape Pattern.","authors":"Lucy Hickcox, Sharon Bates, Mehrnoosh Hashemzadeh, Mohammad Reza Movahed","doi":"10.1097/HPC.0000000000000326","DOIUrl":"10.1097/HPC.0000000000000326","url":null,"abstract":"Background: High heart rate (HR) is independently associated with higher cardiovascular mortality and usually occurs in sedentary persons. Inactivity can also lead to obesity. The purpose of this study was to evaluate the associations between body mass index as an independent marker of high HR.Method: Data generated from screening echocardiography, for the prevention of sudden death at the Anthony Bates Foundation, was used. Data from 1340 subjects, with documented HR and body mass index, between the ages 19-79 years with a mean age of 32 years, were studied. We correlated the presence of a high HR >90 beats per minute (bpm) with different body mass index (BMI) categories.Results: High HR was significantly associated with higher BMI categories and underweight subjects in adults suggesting a J shape association. A total of 22.7% of participants with an HR of more than 90 bpm had BMI >40 kg/m 2 , versus 19.0% of patients with BMI of 35-40 kg/m 2 versus 13.5% of subjects with BMI of 30-35 kg/m 2 versus 12.2% of subjects with BMI of 25-30 kg/m 2 -29.9 kg/m 2 , versus in 10.3% of subjects with BMI between 18.5 and 25 kg/m 2 , P < 0.01) Furthermore, increased HR was also more prevalent in underweight patient (17.4% in subjects with BMI < 18.5 kg/m 2 ).Conclusion: High HR is strongly associated with obesity and underweight suggesting that maintaining a normal weight is associated with most positive effect on the cardiovascular system.","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10101067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Emergency Department Observation Unit Patients Want Evaluation and Treatment for Hypercholesterolemia: A Health Belief Model Study. 急诊科观察室高胆固醇血症患者需要评估和治疗：健康信念模型研究。

Critical Pathways in Cardiology Pub Date : 2023-09-01 Epub Date: 2023-07-07 DOI: 10.1097/HPC.0000000000000324

Nicklaus P Ashburn, Anna C Snavely, Laurie S Stanek, Michael D Shapiro, Rishi R Rikhi, Michael A Chado, Jason P Stopyra, Simon A Mahler

{"title":"Emergency Department Observation Unit Patients Want Evaluation and Treatment for Hypercholesterolemia: A Health Belief Model Study.","authors":"Nicklaus P Ashburn, Anna C Snavely, Laurie S Stanek, Michael D Shapiro, Rishi R Rikhi, Michael A Chado, Jason P Stopyra, Simon A Mahler","doi":"10.1097/HPC.0000000000000324","DOIUrl":"10.1097/HPC.0000000000000324","url":null,"abstract":"Background: Hypercholesterolemia (HCL) is common among emergency department (ED) and ED observation unit (EDOU) patients with chest pain but is not typically addressed in these settings. The objective of this study was to assess patient attitudes towards EDOU-based HCL care using the Health Belief Model.Methods: We conducted a cross-sectional survey study among 100 EDOU patients ≥18 years-old evaluated for chest pain in the EDOU of a tertiary care center from September 1, 2020, to November 01, 2021. Five-point Likert-scale surveys were used to assess each Health Belief Model domain: Cues to Action, Perceived Susceptibility, Perceived Barriers, Perceived Self-Efficacy, and Perceived Benefits. Responses were categorized as agree or do not agree.Results: The participants were 49.0% (49/100) female, 39.0% (39/100) non-white, and had a mean age of 59.0 ± 12.4 years. Most (83.0% [83/100, 95% confidence interval (CI), 74.2%-89.8%]) agreed the EDOU is an appropriate place for HCL education and 52.0% (52/100, 95% CI, 41.8%-62.1%) were interested in talking with their EDOU care team about HCL. Regarding Perceived Susceptibility, 88.0% (88/100, 95% CI, 80.0%-93.6%) believed HCL to be bad for their health, while 41.0% (41/100, 95% CI, 31.3%-51.3%) believed medication costs could be a barrier. For Perceived Self-Efficacy, 76.0% (76/100, 95% CI, 66.4%-84.0%) were receptive to taking medications. Overall, 95.0% (95/100, 95% CI, 88.7%-98.4%) believed managing HCL would benefit their health.Conclusions: This Health Belief Model-based survey indicates high patient interest in EDOU-initiated HCL care. Patients reported high rates of Perceived Susceptibility, Self-Efficacy, and Benefits and a minority found HCL therapy costs a barrier.","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10047246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Transcatheter Leadless Pacemaker for the Treatment of Vasovagal Syncope. 经导管无导线起搏器治疗血管性晕厥。

Critical Pathways in Cardiology Pub Date : 2023-09-01 Epub Date: 2023-05-31 DOI: 10.1097/HPC.0000000000000325

Anis John Kadado, Kyle Gobeil, Jishu Motta, Fadi Chalhoub

引用次数: 0

Cardiovascular Toxicity Associated With Immune Checkpoint Inhibitor Therapy: A Comprehensive Review. 免疫检查点抑制剂治疗的心血管毒性：综述。

Critical Pathways in Cardiology Pub Date : 2023-09-01 Epub Date: 2023-06-26 DOI: 10.1097/HPC.0000000000000327

Mandana Chitsazan, Ahmad Amin, Luisa Ladel, Alyza Baig, Mitra Chitsazan

{"title":"Cardiovascular Toxicity Associated With Immune Checkpoint Inhibitor Therapy: A Comprehensive Review.","authors":"Mandana Chitsazan, Ahmad Amin, Luisa Ladel, Alyza Baig, Mitra Chitsazan","doi":"10.1097/HPC.0000000000000327","DOIUrl":"10.1097/HPC.0000000000000327","url":null,"abstract":"Immune checkpoint inhibitors (ICIs), a significant breakthrough treatment of cancer, exert their function through enhancing the immune system's ability to recognize and attack cancer cells. However, these revolutionary cancer treatments have been associated with a range of immune-related adverse effects, including cardiovascular toxicity. The most commonly reported cardiovascular toxicities associated with ICIs are myocarditis, pericarditis, arrhythmias, and vasculitis. These cardiovascular manifestations are often severe and can lead to life-threatening complications. Therefore, prompt identification and management of these toxicities is critical, and a multidisciplinary teamwork by cardiologists and oncologists are required to ensure optimal patient outcomes. In this review, we summarize the current knowledge on the mechanisms underlying ICI-associated cardiovascular toxicity, clinical presentations of these toxicities, potential risk factors, diagnosis, management, and surveillance strategies during ICI therapy. While ICIs have already transformed cancer treatment, further research is needed to better understand and manage their immune-related cardiovascular effects, and possibly, to identify biomarkers which can predict the occurrence of these cardiovascular complications.","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10044806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Caffeine Drug Interactions and its Clinical Implication After Acute Coronary Syndrome: A Literature Review. 急性冠状动脉综合征后咖啡因与药物的相互作用及其临床意义：文献综述。

Critical Pathways in Cardiology Pub Date : 2023-09-01 Epub Date: 2023-05-09 DOI: 10.1097/HPC.0000000000000322

Ramin Yaghoobian, Mohammad Sharifi, Malihe Rezaee, Hamed Vahidi, Negin Salehi, Kaveh Hosseini

引用次数: 0

Role of Cardiac Biomarkers in Monitoring Cardiotoxicity in Chemotherapy Patients. 心脏生物标志物在监测化疗患者心脏毒性中的作用。

Critical Pathways in Cardiology Pub Date : 2023-09-01 Epub Date: 2023-02-17 DOI: 10.1097/HPC.0000000000000314

Ayman Battisha, Khalid Sawalha, Yasin Obeidat, Brijesh Patel

{"title":"Role of Cardiac Biomarkers in Monitoring Cardiotoxicity in Chemotherapy Patients.","authors":"Ayman Battisha, Khalid Sawalha, Yasin Obeidat, Brijesh Patel","doi":"10.1097/HPC.0000000000000314","DOIUrl":"10.1097/HPC.0000000000000314","url":null,"abstract":"Purpose: This review aims to highlight the different types of chemotherapy-induced cardiotoxicity and will discuss the evidence base behind the use of different cardiac biomarkers to predict cardiovascular complications. Additionally, we will review the use of cardiac biomarkers to monitor cardiac outcomes and the role of cardioprotective medications in reducing cardiovascular side effects.Recent findings: Chemotherapy has been linked to an increased risk of cardiotoxicity and heart failure. Currently, patients receiving chemotherapy undergo echocardiogram before starting chemotherapy and every 6 months to monitor for any decline in cardiac function. We reviewed the current evidence and practice guidelines of monitoring chemotherapy cardiotoxicity.Summary: Cardio-oncology is a rapidly evolving subspecialty in cardiology, especially with the advent of new chemotherapeutic agents, which have cardiovascular side effects. Early detection of these effects is crucial to prevent life-threatening and irreversible cardiovascular outcomes. Monitoring troponin, pro-brain natriuretic peptide, and other cardiac biomarkers during chemotherapy will help to early detect cardiotoxicity.","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10055254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Twenty Years of an Institutional Chest Pain Pathway: What's Come and What's Yet to Come. 机构胸痛路径二十年：过去与未来。

Critical Pathways in Cardiology Pub Date : 2023-06-01 Epub Date: 2023-02-17 DOI: 10.1097/HPC.0000000000000315

Robert S Zilinyi, Jennifer A Stant, Osman R Sayan, Michael B Collins, LeRoy E Rabbani

引用次数: 0

The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic. COVID-19大流行期间肺动脉高压和慢性血栓栓塞性肺动脉高压患者的预后

Critical Pathways in Cardiology Pub Date : 2023-06-01 DOI: 10.1097/HPC.0000000000000317

Alireza Serati, Mohammad Sadegh Keshmiri, Shadi Shafaghi, Majid Malek Mohammad, Babak Sharif Kashani, Farah Naghashzadeh, Arezoo Mohamadifar, Masoud Shafaghi, Sima Noorali, Maryam Hajimoradi, Bahamin Astani, Sina Aghdasi, Mahsa Riahi, Sima Alavi, Rayka Malek, Mohammad Reza Movahed

{"title":"The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.","authors":"Alireza Serati, Mohammad Sadegh Keshmiri, Shadi Shafaghi, Majid Malek Mohammad, Babak Sharif Kashani, Farah Naghashzadeh, Arezoo Mohamadifar, Masoud Shafaghi, Sima Noorali, Maryam Hajimoradi, Bahamin Astani, Sina Aghdasi, Mahsa Riahi, Sima Alavi, Rayka Malek, Mohammad Reza Movahed","doi":"10.1097/HPC.0000000000000317","DOIUrl":"https://doi.org/10.1097/HPC.0000000000000317","url":null,"abstract":"Background: The coronavirus 2019 (COVID-19) has affected the lives of many people worldwide. Patients with chronic underlying morbidities are vulnerable to get the severe form of the infection. The goal of this study was to evaluate the outcome of patients with pulmonary arterial hypertension during the COVID-19 pandemic in Iran.Methods: This cross-sectional study was conducted at a large tertiary center for pulmonary artery hypertension (PAH) patients. The primary end point was the prevalence of SARS-CoV-2 infection in PAH patients. The secondary end points were investigating the severity and mortality of COVID-19 infection in PAH patients during the COVID-19 pandemic.Results: Totally 75 patients were enrolled in the study from December 2019 to October 2021 and 64% were female. The mean ± SD age was 49 ± 16 years. The prevalence of COVID-19 in PAH/chronic thromboembolic pulmonary hypertension patients was 44%. About 66.7% of patients had comorbidities, which was a prognostic factor for COVID-19 infection in PAH patients (P < 0.001). Fifty-six percent of infected patients were asymptomatic. The most reported symptoms in symptomatic patients were fever (28%) and malaise (29%). Twelve percent of patients were admitted with severe symptoms. The mortality rate in infected individuals was 3.7%.Conclusions: COVID-19 infection in PAH/chronic thromboembolic pulmonary hypertension patients seems to be associated with high mortality and morbidity. More scientific proof is needed to clarify different aspect of COVID-19 infection in this population.","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9687690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Presence of Pneumonia Is Strongly Associated With Higher Prevalence of Non-ST-Elevation Myocardial Infarction Using a Large NIS Database. 使用大型NIS数据库，肺炎的存在与非st段抬高型心肌梗死的高患病率密切相关。

Critical Pathways in Cardiology Pub Date : 2023-06-01 DOI: 10.1097/HPC.0000000000000319

Manrit Gill, Mohammad Reza Movahed, Mehrtash Hashemzadeh, Mehrnoosh Hashemzadeh

{"title":"The Presence of Pneumonia Is Strongly Associated With Higher Prevalence of Non-ST-Elevation Myocardial Infarction Using a Large NIS Database.","authors":"Manrit Gill, Mohammad Reza Movahed, Mehrtash Hashemzadeh, Mehrnoosh Hashemzadeh","doi":"10.1097/HPC.0000000000000319","DOIUrl":"https://doi.org/10.1097/HPC.0000000000000319","url":null,"abstract":"Objective: Inflammation is a risk factor for myocardial infarction. Pneumonia leads to severe inflammatory response. Some studies suggest higher risk of myocardial infarction in patients with pneumonia. We used a large inpatient database (National Inpatient Sample) to evaluate this association.Methods: This study includes patients from a Nationwide Inpatient Sample hospital in 2005 to 2014 with International Classification of Diseases, Ninth Revision, and Clinical Modification codes consistent with pneumonia and non-ST elevation myocardial infarction (NSTEMI). Subjects were stratified into all hospitalized patients aged 30 and above. Univariate and multivariate analysis was performed adjusting for age, race, gender, tobacco use, diabetes mellitus, hypertension, and hyperlipidemia.Results: NSTEMI was present in 3.2% of pneumonia patients versus 1.8% in the non-pneumonia population over 10-year period. For example, the 2005 database: [odds ratio (OR), 1.77; 95% confidence interval (CI), 1.73-1.80; P < 0.001]. For 2014, NSTEMI was present in 4.1% of pneumonia patients (PNA) versus 2.4% in the non-pneumonia population (OR, 1.72; 95% CI, 1.70-1.75; P < 0.001). NSTEMI remained independently associated with pneumonia following a multivariate analysis in 2005 (OR, 1.477; 95% CI, 1.447-1.508; P < 0.001) with a similar value in 2014 (OR, 1.445; 95% CI, 1.421-1.469; P < 0.001).Conclusions: Using a large inpatient database, we found that NSTEMI was strongly associated with PNA versus non-pneumonia population over a 10-year period. Suggesting acute inflammatory cytokines or hypoxia which occurs during lung infection may play a role in NSTEMI development, reinforcing the importance of acute cardiac monitoring in patients with PNA.","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10205740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0